Henry M L, Ketel B L, Elkhammas E A, Tesi R J, Ferguson R M
Department of Surgery, Ohio State University College of Medicine, Columbus.
Clin Transpl. 1990:203-15.
At our center, KPT is the treatment of choice for diabetics with ESRD who are not irreversibly disabled by their secondary complications of diabetes. Mortality, as a result of cardiovascular complications, has a significant impact on the outcome of patients in both the KPT and KTA groups. Metabolic complications are problematic in the early posttransplant period. Infectious complications are frequent but not life threatening in the combined recipients. Excellent graft outcome (pancreas and kidney) can be achieved in those patients selected to undergo the KPT procedure.
在我们中心，对于那些未因糖尿病继发并发症而导致不可逆残疾的终末期肾病糖尿病患者，胰肾联合移植（KPT）是首选的治疗方法。心血管并发症导致的死亡率对KPT组和肾移植（KTA）组患者的预后都有重大影响。代谢并发症在移植后的早期阶段是个问题。感染性并发症很常见，但在联合受者中并不危及生命。对于那些被选择接受KPT手术的患者，可以实现优异的移植物（胰腺和肾脏）预后。
